Trials / Completed
CompletedNCT03114904
Comparison of the Efficacy of a Protocol for the Withdrawal of Neurosedation From the Usual Strategy in Cerebroses
Comparison of the Efficacy of a Protocol for the Withdrawal of Neurosedation From the Usual Strategy in Cerebroses: Randomized Controlled Trial.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Centre Hospitalier Universitaire, Amiens · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The withdrawal syndrome in benzodiazepines and morphine is common in intensive care, the incidence is estimated at 32.1%. Cerebrospatized patients are probably more prone to withdrawal because they require high doses of sedation. Moreover, this syndrome is probably deleterious on the cerebral hemodynamics (high point of the therapeutic management).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Variation of Jasinski score between H0 (stop of sedatives) and H6 | To compare the effectiveness of a withdrawal management protocol with the usual management in cerebral patients (Subarachnoid haemorrhage (HSA), stroke and head trauma (CT)) |
Timeline
- Start date
- 2016-02-27
- Primary completion
- 2018-05-16
- Completion
- 2018-05-16
- First posted
- 2017-04-14
- Last updated
- 2020-07-20
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03114904. Inclusion in this directory is not an endorsement.